DPP4 and COVID-19: Regarding the synergistic side effects between the COVID-19 vaccine and medications, there have been reports highlighting the potential for the onset of bullous pemphigoid when taking dipeptidyl peptidase 4 inhibitors (DPP4-i) after COVID-19 vaccination [19].